PortfoliosLab logoPortfoliosLab logo
PRTH vs. HRMY
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

PRTH vs. HRMY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Priority Technology Holdings, Inc. (PRTH) and Harmony Biosciences Holdings, Inc. (HRMY). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

PRTH vs. HRMY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
PRTH
Priority Technology Holdings, Inc.
-13.39%-53.62%230.06%-32.32%-25.71%0.57%199.57%
HRMY
Harmony Biosciences Holdings, Inc.
-25.15%8.75%6.53%-41.38%29.22%17.95%-2.32%

Fundamentals

Market Cap

PRTH:

$394.70M

HRMY:

$1.64B

EPS

PRTH:

$0.68

HRMY:

$3.33

PE Ratio

PRTH:

6.91

HRMY:

8.41

PEG Ratio

PRTH:

0.00

HRMY:

0.08

PS Ratio

PRTH:

0.40

HRMY:

1.89

Total Revenue (TTM)

PRTH:

$953.01M

HRMY:

$868.45M

Gross Profit (TTM)

PRTH:

$233.30M

HRMY:

$670.11M

EBITDA (TTM)

PRTH:

$153.35M

HRMY:

$238.25M

Returns By Period

In the year-to-date period, PRTH achieves a -13.39% return, which is significantly higher than HRMY's -25.15% return.


PRTH

1D
0.43%
1M
-14.95%
YTD
-13.39%
6M
-31.30%
1Y
-30.74%
3Y*
9.55%
5Y*
-8.25%
10Y*

HRMY

1D
4.13%
1M
-1.86%
YTD
-25.15%
6M
1.63%
1Y
-15.61%
3Y*
-4.98%
5Y*
-2.68%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PRTH vs. HRMY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PRTH
PRTH Risk / Return Rank: 2020
Overall Rank
PRTH Sharpe Ratio Rank: 1919
Sharpe Ratio Rank
PRTH Sortino Ratio Rank: 2222
Sortino Ratio Rank
PRTH Omega Ratio Rank: 2222
Omega Ratio Rank
PRTH Calmar Ratio Rank: 2020
Calmar Ratio Rank
PRTH Martin Ratio Rank: 1919
Martin Ratio Rank

HRMY
HRMY Risk / Return Rank: 2525
Overall Rank
HRMY Sharpe Ratio Rank: 2525
Sharpe Ratio Rank
HRMY Sortino Ratio Rank: 2525
Sortino Ratio Rank
HRMY Omega Ratio Rank: 2424
Omega Ratio Rank
HRMY Calmar Ratio Rank: 2828
Calmar Ratio Rank
HRMY Martin Ratio Rank: 2525
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PRTH vs. HRMY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Priority Technology Holdings, Inc. (PRTH) and Harmony Biosciences Holdings, Inc. (HRMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PRTHHRMYDifference

Sharpe ratio

Return per unit of total volatility

-0.51

-0.37

-0.14

Sortino ratio

Return per unit of downside risk

-0.37

-0.24

-0.13

Omega ratio

Gain probability vs. loss probability

0.95

0.96

-0.02

Calmar ratio

Return relative to maximum drawdown

-0.65

-0.45

-0.19

Martin ratio

Return relative to average drawdown

-1.20

-0.98

-0.22

PRTH vs. HRMY - Sharpe Ratio Comparison

The current PRTH Sharpe Ratio is -0.51, which is lower than the HRMY Sharpe Ratio of -0.37. The chart below compares the historical Sharpe Ratios of PRTH and HRMY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


PRTHHRMYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.51

-0.37

-0.14

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.11

-0.05

-0.06

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.10

-0.09

-0.01

Correlation

The correlation between PRTH and HRMY is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

PRTH vs. HRMY - Dividend Comparison

Neither PRTH nor HRMY has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

PRTH vs. HRMY - Drawdown Comparison

The maximum PRTH drawdown since its inception was -88.12%, which is greater than HRMY's maximum drawdown of -68.48%. Use the drawdown chart below to compare losses from any high point for PRTH and HRMY.


Loading graphics...

Drawdown Indicators


PRTHHRMYDifference

Max Drawdown

Largest peak-to-trough decline

-88.12%

-68.48%

-19.64%

Max Drawdown (1Y)

Largest decline over 1 year

-46.48%

-34.49%

-11.99%

Max Drawdown (5Y)

Largest decline over 5 years

-63.62%

-68.48%

+4.86%

Current Drawdown

Current decline from peak

-61.59%

-54.01%

-7.58%

Average Drawdown

Average peak-to-trough decline

-42.72%

-34.74%

-7.98%

Ulcer Index

Depth and duration of drawdowns from previous peaks

25.07%

15.95%

+9.12%

Volatility

PRTH vs. HRMY - Volatility Comparison

Priority Technology Holdings, Inc. (PRTH) has a higher volatility of 11.24% compared to Harmony Biosciences Holdings, Inc. (HRMY) at 8.18%. This indicates that PRTH's price experiences larger fluctuations and is considered to be riskier than HRMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


PRTHHRMYDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.24%

8.18%

+3.06%

Volatility (6M)

Calculated over the trailing 6-month period

48.21%

31.02%

+17.19%

Volatility (1Y)

Calculated over the trailing 1-year period

60.68%

41.98%

+18.70%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

74.99%

50.63%

+24.36%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

75.88%

52.83%

+23.05%

Financials

PRTH vs. HRMY - Financials Comparison

This section allows you to compare key financial metrics between Priority Technology Holdings, Inc. and Harmony Biosciences Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


50.00M100.00M150.00M200.00M250.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
247.13M
243.78M
(PRTH) Total Revenue
(HRMY) Total Revenue
Values in USD except per share items

PRTH vs. HRMY - Profitability Comparison

The chart below illustrates the profitability comparison between Priority Technology Holdings, Inc. and Harmony Biosciences Holdings, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober0
71.9%
Portfolio components
PRTH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Priority Technology Holdings, Inc. reported a gross profit of 0.00 and revenue of 247.13M. Therefore, the gross margin over that period was 0.0%.

HRMY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Harmony Biosciences Holdings, Inc. reported a gross profit of 175.23M and revenue of 243.78M. Therefore, the gross margin over that period was 71.9%.

PRTH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Priority Technology Holdings, Inc. reported an operating income of 33.50M and revenue of 247.13M, resulting in an operating margin of 13.6%.

HRMY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Harmony Biosciences Holdings, Inc. reported an operating income of 38.56M and revenue of 243.78M, resulting in an operating margin of 15.8%.

PRTH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Priority Technology Holdings, Inc. reported a net income of 8.95M and revenue of 247.13M, resulting in a net margin of 3.6%.

HRMY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Harmony Biosciences Holdings, Inc. reported a net income of 59.03M and revenue of 243.78M, resulting in a net margin of 24.2%.